COMP <GO>
CBZ vs PG // FORWARD P/E MULTIPLE
CBIZ Inc. (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: CBZ 5
— PG 8
■ METRIC PARITY
LAST: $54.98 (0.00%) • MKT CAP: $2.98B
forward-pe
21.7x
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
forward-pe
21.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CBZ VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CBZ | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 12.90% | 51.20% | -38.30 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.90% | 25.40% | -19.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.5x | 16.2x | +1.30 | PG | /valuation <GO> |
| Free Cash Flow Yield | 5.88% | 3.77% | +2.11 | CBZ | /fcf-yield <GO> |
| Operating Margin | 8.50% | 24.30% | -15.80 | PG | /operating-margins <GO> |
| Net Profit Margin | 4.20% | 19.00% | -14.80 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 52.10% | 0.30% | +51.80 | CBZ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.84 | 5.59 | -3.75 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | CBZ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.50% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.3 | 62.7 | +5.66 | CBZ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.87 | +0.02 | CBZ | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 21.7x | 21.7x | 0.00 | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.98B | $372.21B | -$369.23B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CBZ REV | PG REV | CBZ GROSS % | PG GROSS % | CBZ FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.76B | $84.28B | 12.9% | 51.2% | $175.5M | $14.04B |
| FY 2024 | $1.81B | $84.04B | 10.1% | 51.4% | $110.8M | $16.52B |
| FY 2023 | $1.59B | $82.01B | 44.0% | 44.0% | $81.9M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CBZ // BETA 0.89
PG // BETA 0.87